CHERUVU PAVAN (Chief Executive Officer) received a stock award from SIO GENE THERAPIES INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/19/2021ACC: 0001636050-21-000027
DirectorOfficer· Chief Executive Officer
Since Apr 2019
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
22.59K acquired · 22.59K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+22.59K
Price / share
—
Trade value
—
% of position
39.1%
3/17/2021
57.84K→80.43K
Total
Net shares
+22.59K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2021 | A · Award | +22.59K | — | — | 39.1% | 57.84K | 80.43K |
| Total | +22.59K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
22.59K shares
Shares
−22.59K
Strike price
Held after
0.00
Exercisable
—
3/17/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock22.59K shares | 3/17/2021 | D · Disposition | −22.59K | — | 0.00 |